Posted on 09/24/2018 5:26:10 PM PDT by Faith Presses On
WASHINGTON — 85 members of Congress have signed a joint letter urging the Food and Drug Administration (FDA) to cancel its contract with a biomedical procurement company to purchase “fetal tissue” that will be used to create mice with a human immune system in order to test drug safety and efficacy.
“Unborn children are not commodities to be bought and sold,” the letter reads. “The practice of conducting research using the body parts of children whose lives have been violently ended by abortion is abhorrent.”
As previously reported, the FDA had posted a pre-solicitation notice in June outlining its intentions to contract with Advanced Bioscience Resources to obtain what it called “fetal tissue” for research.
(Excerpt) Read more at christiannews.net ...
In the current battle over Judge Kavanaugh’s nomination, one must consider whether the millions of souls of the innocent denied their rights to life and liberty are not crying out in unison to the Creator of us all.
300 and some odd are fine with it. Sickos. anybody remember Jonathan Swift? A modest proposal?
Now we literally buy and sell baby parts. It used to be high satire about Englands lack of compassion for Irish babies. Now we do things more insane than he could imagine.
You mean our tax dollars are being used to buy baby tissue for experimentation? If that is the case, our own government makes every taxpayer a merchant of human flesh. How many taxpayers know about this?
That’s some good news today.
Only 85? Sad.
Did the Speaker of the House, Paul Ryan sign? I could not find his ‘holy’ name.
http://www.freerepublic.com/focus/f-news/3691233/posts
Trump Administration Cancels FDA’s Aborted-Baby-Parts Contract
www.cnsnews.com ^ | September 25, 2018 | 10:08 PM EDT | By Terence P. Jeffrey
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.